Juvenile Arthritis Helped by Adult Meds

JUNE 01, 2005

A recent study in the New England Journal of Medicine touted the efficacy of adult arthritis drugs methotrexate and leflunomide (Arava) in treating children with arthritis. Whereas methotrexate has been used for years to treat children with arthritis, it now has been shown to be effective at higher doses. The FDA has approved Arava for adult use but not for treating children.

Patients given the higher dose of methotrexate had a 90% response rate, while patients taking Arava had a 68% response rate. Both drugs help control the white blood cells that cause inflammation and pain associated with arthritis. The study was funded by Sanofi-Aventis, manufacturer of both drugs.



SHARE THIS SHARE THIS
0

Become a Respimat Top Performer 

Get to know RESPIMAT, the slow-moving mist inhaler from Boehringer Ingelheim Pharmaceuticals, Inc. 

Watch the RESPIMAT video and test your knowledge with a short multiple-choice quiz. When you get all the answers right, you’ll receive a certificate naming you a RESPIMAT T.O.P. Performer. Why not check it out today? 

 

Pharmacy Times Strategic Alliance
 

Pharmacist Education
Clinical features with downloadable PDFs


Next-Generation Pharmacist® Awards


3rd Annual Convenient Healthcare and Pharmacy Collaborative Conference


SIGN UP FOR THE PHARMACY TIMES NEWSLETTER
Personalize the information you receive by selecting targeted content and special offers.